Our results also indicate that the expression of IL6, IL8, or IL18 alone has a satisfactory capability to distinguish the GDM patients from healthy pregnancies at the time of GDM diagnosis; thus, each of these genes possesses the potential to serve as a good molecular biomarker helping to identify GDM patients. This evidence concerns the gene CXCL8 and gestational diabetes.